USA Today

Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 500 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the ...

Nostrum Laboratories, Inc. is voluntarily recalling 2 (two) lots of Metformin HCl Extended Release Tablets, USP 500 mg to the consumer level. The Metformin HCl Extended Release Tablets, USP 500 mg ...
Medscape

Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes

All extended-release metformin treatment regimens produced significant decreases in A1C levels that were similar to those with the comparator, immediate-release metformin, a widely used and highly ...
Business Wire

Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (metformin hydrochloride for extended-release oral suspension) Due to N ...

PRINCETON, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER™ ...
Business Insider

Information Update - Apotex Inc. recalls certain lots of the diabetes medication APO-Metformin ER (extended release) 500 mg tablets

Apotex Inc. is recalling eight lots of its 500 mg extended release metformin tablets ("APO-Metformin ER") because they contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) above the ...
Medscape

FDA Recalls Extended-Release Metformin Due to NDMA Impurities

The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin because testing has revealed excessive levels of ...
Miami Herald

Fifth diabetes medicine recalled for containing too much of a ‘probable carcinogen’

Thursday, Lupin Pharmaceuticals announced its recall of Metformin Hydrochloride Extended-Release Tablets after the FDA found the Type 2 diabetes medicine exceeded standards for NDMA. Though NDMA ...
Miami Herald

Diabetes medicine recalled for having too much of a carcinogen. More recalls are likely

Apotex has recalled all its Metformin Hydrochloride Extended-Release Tablets 500 mg in the United States for too much of carcinogen NDMA, the same “impurity” that got all the Zantac yanked earlier ...
FierceBiotech

Dapagliflozin with Metformin Extended-Release as Initial Combination Therapy Improved Blood Sugar Control in Type 2 Diabetes

Investigational Compound Dapagliflozin with Metformin Extended-Release (XR) as Initial Combination Therapy Significantly Improved Blood Sugar Control in Previously-Untreated Adult Type 2 Diabetes ...
FiercePharma

KOMBIGLYZE™ XR (Saxagliptin and Metformin HCl Extended-Release) Tablets Approved in the U.S. for the Treatment of Type 2 D

PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced that the U.S. Food and Drug Administration (FDA) approved KOMBIGLYZE ™ ...
Healio

FDA requests voluntary recall of contaminated metformin products

Please provide your email address to receive an email when new articles are posted on . The FDA has asked five drug manufacturers to voluntarily recall several lots of extended-release metformin after ...
FiercePharma

KOMBIGLYZE™ XR (Saxagliptin and Metformin HCl Extended-Release) Tablets, a New Treatment for Type 2 Diabetes Mellitu

PRINCETON, N.J. & LONDON--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY), and AstraZeneca (NYSE: AZN) today announced that KOMBIGLYZE ™ XR (saxagliptin and metformin HCl extended-release), ...